These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 31706809)

  • 1. Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.
    Browne SK; Beeler JA; Roberts JN
    Vaccine; 2020 Jan; 38(2):101-106. PubMed ID: 31706809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
    Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro model for the assessment of human immune responses to subunit RSV vaccines.
    Chirkova T; Ha B; Rimawi BH; Oomens AGP; Hartert TV; Anderson LJ
    PLoS One; 2020; 15(3):e0229660. PubMed ID: 32191728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    Wang Y; Ge F; Wang J; Li H; Zheng B; Li W; Chen S; Zheng X; Deng Y; Wang Y; Zeng R
    J Virol; 2023 Mar; 97(3):e0176422. PubMed ID: 36779760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.
    Muralidharan A; Li C; Wang L; Li X
    Expert Rev Vaccines; 2017 Apr; 16(4):351-360. PubMed ID: 27841687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4
    Schneider-Ohrum K; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; Cheng LI; O'Day T; Cayatte C
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016.
    Giersing BK; Karron RA; Vekemans J; Kaslow DC; Moorthy VS
    Vaccine; 2019 Nov; 37(50):7355-7362. PubMed ID: 28302410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
    Rainisch G; Adhikari B; Meltzer MI; Langley G
    Vaccine; 2020 Jan; 38(2):251-257. PubMed ID: 31740097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease.
    Shaw CA; Galarneau JR; Bowenkamp KE; Swanson KA; Palmer GA; Palladino G; Markovits JE; Valiante NM; Dormitzer PR; Otten GR
    Vaccine; 2013 Jan; 31(2):306-12. PubMed ID: 23153444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lungs.
    Zhang L; Li H; Hai Y; Yin W; Li W; Zheng B; Du X; Li N; Zhang Z; Deng Y; Zeng R; Wei L
    J Virol; 2017 May; 91(10):. PubMed ID: 28275186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Historical Perspective on Respiratory Syncytial Virus Prevention: A Journey Spanning Over Half a Century From the Setback of an Inactive Vaccine Candidate to the Success of Passive Immunization Strategy.
    Noor A; Krilov LR
    J Pediatric Infect Dis Soc; 2024 Jul; 13(Supplement_2):S103-S109. PubMed ID: 38577737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types.
    Atherton LJ; Jorquera PA; Bakre AA; Tripp RA
    Front Immunol; 2019; 10():2323. PubMed ID: 31649663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subunit and virus-like particle vaccine approaches for respiratory syncytial virus.
    Morrison TG; Walsh EE
    Curr Top Microbiol Immunol; 2013; 372():285-306. PubMed ID: 24362695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preventive effect of vaccine prophylaxis on severe respiratory syncytial virus infection: A meta-analysis.
    Zhu T; Zhang C; Yu L; Chen J; Qiu H; Lyu W; Huang S
    Virol Sin; 2015 Oct; 30(5):371-8. PubMed ID: 26511990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    Fleming-Dutra KE; Jones JM; Roper LE; Prill MM; Ortega-Sanchez IR; Moulia DL; Wallace M; Godfrey M; Broder KR; Tepper NK; Brooks O; Sánchez PJ; Kotton CN; Mahon BE; Long SS; McMorrow ML
    MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(41):1115-1122. PubMed ID: 37824423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of vaccines to prevent respiratory syncytial virus infection in infants and older adults: A systematic review and meta-analysis.
    Zeng B; Liu X; Yang Q; Wang J; Ren Q; Sun F
    Int J Infect Dis; 2024 Sep; 146():107118. PubMed ID: 38878994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist.
    Frenkel LD; Gaur S; Bellanti JA
    Allergy Asthma Proc; 2023 Jul; 44(4):220-228. PubMed ID: 37236777
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with respiratory syncytial virus vaccines.
    Piedra PA
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.